Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
The Journal of Urology|April 25, 2008
Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomyJudd W Moul, Hongyu Wu, Leon Sun, et al.
Urologic Oncology|December 25, 2003
Factors associated with blood loss during radical prostatectomy for localized prostate cancer in the prostate-specific antigen (PSA)-era: an overview of the Department of Defense (DOD) Center for Prostate Disease Research (CPDR) national databaseJudd W Moul, Leon Sun, Hongyu Wu, et al.
Cancer Research|August 9, 2003
PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progressionLinda L Xu, Yinghui Shi, Gyorgy Petrovics, et al.
The Journal of Urology|May 7, 2018
Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with AntiandrogensE David Crawford, Paul F Schellhammer, David G McLeod, et al.
Urology|September 7, 2012
Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancerPhilip Rosen, David Pfister, Denise Young, et al.
The Prostate|March 27, 2015
Prostate cancer marker panel with single cell sensitivity in urineKristen P Nickens, Amina Ali, Tatiana Scoggin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Diagnostic potential of prostate-specific antigen expressing epithelial cells in blood of prostate cancer patientsChun-Ling Gao, Sudhir K Rawal, Leon Sun, et al.
Oncotarget|April 18, 2015
Silencing of PMEPA1 accelerates the growth of prostate cancer cells through AR, NEDD4 and PTENHua Li, Ahmed A Mohamed, Shashwat Sharad, et al.
Urologic Nursing|January 26, 2008
The design and implementation of a multidisciplinary prostate cancer clinicJane L Hudak, David G McLeod, Stephen A Brassell, et al.
Urology|March 18, 2003
Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the Center for Prostate Disease Research nomogramsKevin J Gancarczyk, Hongyu Wu, David G McLeod, et al.
Pageof 12